Prognostic value of Ki-67 index in malignant phyllodes tumor of the breast: a multi-center real-world study [0.03%]
Ki-67指数在恶性叶状肿瘤预后中的价值：一项多中心真实世界研究
Yiran Zhou,Changyuan Guo,Yan Wang et al.
Yiran Zhou et al.
Prophylactic and therapeutic CSC-based vaccination reduced tumor growth, metastasis and enhanced survival in mouse model of breast cancer [0.03%]
基于预防和治疗的CSC疫苗接种减少了乳腺癌小鼠模型中的肿瘤生长、转移并延长了生存期
Masoumeh Dehghan Manshadi,Farideh Hashemi,Sadegh Safaei et al.
Masoumeh Dehghan Manshadi et al.
Change in mammographic density as a potential predictor of cancer recurrence after breast conservation surgery and adjuvant endocrine therapy: results of the MEDICI study [0.03%]
MEDICI研究中乳腺癌保乳术后辅助内分泌治疗后乳房密度变化与复发的关系
Sarah L Savaridas,Andrea Marshall,Kulsam Ali et al.
Sarah L Savaridas et al.
Background: Oestrogen-receptor positive breast cancer patients are typically treated with adjuvant endocrine therapy (AET), some develop AET resistance. Previous research suggests mammographic density (MD) may represent a...
Development and cross-validation of a novel multi-omic assay to assess locoregional recurrence risk and adjuvant therapy benefit in early-stage hormone receptor positive invasive breast cancer patients [0.03%]
用于评估早期激素受体阳性侵袭性乳腺癌患者局部区域复发风险和辅助治疗获益的新型多组学检测方法的研发及交叉验证研究
Troy Bremer,Karuna Mittal,Chirag Shah et al.
Troy Bremer et al.
Lymphatic pumping failure in the arm precedes dermal backflow and breast cancer-related lymphedema [0.03%]
手臂淋巴泵衰竭先于皮肤反流和乳腺癌相关淋巴水肿发生
Melissa B Aldrich,Meghan E McWain,Simona F Shaitelman et al.
Melissa B Aldrich et al.
4-Hydroxybutyrate (4HB) released from Poly-4-hydroxybutyrate scaffolds does not impact hallmark phenotypes of cancer in malignant or non-malignant breast cells [0.03%]
聚4-羟基丁酸酯支架释放的4-羟基丁酸盐不会影响恶性或非恶性乳腺细胞中癌症标志性表型
Sakib F Elahi,David P Martin,Yong Wan et al.
Sakib F Elahi et al.
Vascular abnormalization confers tumor resistance to antiangiogenic therapy via downregulating angiostatic factors [0.03%]
血管异常化通过下调抗血管生成因子赋予肿瘤抗血管生成治疗抵抗性
Xunyuan Mao,Xiangyu Cao,Long Qian et al.
Xunyuan Mao et al.
O-GlcNAcylation regulates the DNA damage repair function of MND1 in breast cancer [0.03%]
O-GlcNAc酰化通过调节乳腺癌中的MND1 DNA修复功能起致癌作用
Zhen Zhai,Jinpeng Wu,Yumeng Wei et al.
Zhen Zhai et al.
Tumor heterogeneity index from DCE-MRI for AKT-inhibition responder identification and reveals hot immune microenvironment for patients with breast cancer: a multi-omics analysis of I-SPY2 trial [0.03%]
基于DCE-MRI的肿瘤异质性指数用于识别乳腺癌AKT抑制剂敏感患者并揭示其“热”免疫微环境：I-SPY2试验多组学分析
Xinzhi Teng,Jiang Zhang,Qingpei Lai et al.
Xinzhi Teng et al.
Background: The pan-AKT inhibitor MK2206 has shown improved but limited efficacy in achieving pathologic complete response (pCR) in patients with breast cancer receiving standard neoadjuvant chemotherapy (NACT). This stud...
Associations of local breast density with patient characteristics and risk of breast cancer among women undergoing diagnostic breast biopsy [0.03%]
局部乳腺密度与接受诊断性乳腺活检的女性患者的临床特征及患癌风险的关系
Aileen Burke,Shaoqi Fan,Ruth M Pfeiffer et al.
Aileen Burke et al.